Previous 10 | Next 10 |
Despite the biotech industry having pockets of extreme and irrational ebullience, the largest part of the industry is systematically underfunded. It's also the highest-value-add part of the industry from a risk-adjusted basis. In this video, we have a philosophical discussion with the CEO of o...
It's time to talk about a new venture called EQRx. This has made quite a splash in the last few days at the JPMorgan investor conference, and it's been launched by Alexis Borisy (involved with founding and/or helping run CombinatoRx, Foundation, Blueprint, WarpDrive Bio, Editas, Relay, and oth...
VanEck Vectors Biotech ETF (NASDAQ: BBH ) - $0.4724 . 30-Day SEC Yield of 0.31% as of Dec 20. Payable Dec 30; for shareholders of record Dec 24; ex-div Dec 23. More news on: VanEck Vectors Biotech ETF, Dividend News, News on ETFs, ,
VanEck announced today the following 2019 annual distributions per share for its VanEck Vectors ® equity exchange-traded funds. The majority, and possibly all, of the dividend distributions will be paid out of net investment income earned by the Funds. A portion of these distributio...
VanEck Vectors Biotech ETF (NASDAQ: BBH ) - $0.4160 . 30-Day SEC Yield of 0.31% as of Nov. 26. Payable Dec 30; for shareholders of record Dec 24; ex-div Dec 23. Press Release More news on: VanEck Vectors Biotech ETF, Dividend News, News on ETFs, ,
VanEck announced today preliminary yearend distribution estimates for its VanEck Vectors ® exchange-traded funds. Please note that capital gains estimates were made as of October 31, 2019 and income estimates were made as of November 20, 2019, and are based upon the best information...
Aprea Therapeutics (NASDAQ: APRE ) opens for trading after raising the size of its IPO to 5.67M shares from 5M and pricing its IPO at $15 , the mid‐point of the $14‐$16 expected range. More news on: Aprea Therapeutics, Monopar Therapeutics, ADC Therapeutics SA, Healthcare st...
(Source - Pexels/Pixbay ) It is widely believed that the Healthcare sector is a safe sector in a recessionary environment because "people always need medical treatment." While that is historically true, it seems that many investors are underweighting the substantial risks in the sector. H...
By Stephen H. Dover, CFA, Executive Vice President, Head of Equities, Krzysztof Musialik, CFA, Research Analyst, Franklin Templeton Emerging Markets Equity, and Steve Kornfeld, CFA, Portfolio Manager, Research Analyst, Franklin Equity Group The biopharma industry has the potential to save...
By Andy Acker, CFA & Luyi Guo, Ph.D., CFA & Rich Carney, CFA Last week, the Trump administration abandoned plans to overhaul drug rebates in Medicare while a federal judge ruled against listing prescription drug prices in TV ads. But U.S. drug reform is far from over, with implica...
News, Short Squeeze, Breakout and More Instantly...
VanEck Vectors Biotech ETF Company Name:
BBH Stock Symbol:
NASDAQ Market:
2024-07-18 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 14:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.7% to $118.11 on volume of 457,565,587 shares Agrify Corporation (AGFY) rose 68.7% to $0.4251 on volume of 291,898,257 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 13.7% to $0.3662 on volume...